Publication of the 4th issue of Cancer Biology & Medicine
Special issue on cancer immunology and immunotherapy
As a peer-reviewed open-access journal, Cancer Biology & Medicine is quarterly published by China Anti-Cancer Association and Tianjin Medical University Cancer Institute & Hospital. It focuses on translational cancer research, dedicating to narrowing the gap between bench and bedside. The journal is now indexed in Science Citation Index Expanded (SCIE, IF=4.248) and Medline. All full texts are available at http://www.ncbi.nlm.nih.gov/pmc/journals/2000/
In order to report the latest advances in cancer immunology and immunotherapy, we published this special issue with sincere appreciation to the Guest Editor Prof. Xiubao Ren (Tianjin Medical University Cancer Institute & Hospital). In particular, his research on the role of ferritin in immune related adverse events is recommended. Besides, Prof. Yusuke Nakamura (Japanese Foundation for Cancer Research) summarized personalized immunotherapy in cancer precision medicine; and Prof. Xiaojun Huang (Peking University People’s Hospital) highlighted the developments of cellular immunotherapy in hematology.
The contents also involve immune evasion, tumor immune microenvironment, immune checkpoint inhibitor, CAR-T cells in treatment, and so on. We hope this issue will greatly benefit your research and clinical practice. Welcome to submit your work to Cancer Biology & Medicine.
Cancer immunology and immunotherapy Xiubao Ren |
Yunfan Sun, Jian Zhou, Jia Fan, Xinrong Yang |
Epithelial cells mimic immune cells: a novel path toward tumor immunotherapy Ruining Gong, Yan Huang, Xiaoxuan Wang, Xiaobing Chen, Zibin Tian, He Ren |
The role of DLL1 in long-term vascular normalization and cancer immunotherapy Qiaozhen Wu, Yuhui Huang |
Repurposing glucocorticoids as adjuvant reagents for immune checkpoint inhibitors in solid cancers Yingyan Yu |
Multiplex imaging reveals the architecture of the tumor immune microenvironment Junlei Zhang, Jinyuan Song, Jianpeng Sheng, Xueli Bai, Tingbo Liang |
Personalized immunotherapy in cancer precision medicine Kazuma Kiyotani, Yujiro Toyoshima, Yusuke Nakamura |
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives Zhengli Xu, Xiaojun Huang |
Hua Zhao, Hao Wang, Qiuru Zhou, Xiubao Ren |
Targeting myeloid-derived suppressor cells for cancer therapy Hongchao Tang, Hao Li, Zhijun Sun |
Ping Li, Fengyang Chen, Jingbin Zheng, Yang Yang, Yuan Li, Yifei Wang, Xin Chen |
EZH2 identifies the precursors of human natural killer cells with trained immunity Chen Zhang, Jie Yin, Jian Zheng, Jun Xiao, Jiajian Hu, Yudong Su, Kaichen Zhou, Yingchi Zhang, Xuzhen Zhang, Hong Zhang, Qian Sun, Yang Wang, Wenwen Yu, Feng Wei, Qiang Zhao, Long Li, Xiubao Ren |
Huihui Yin, Lu Yang, Gongxin Peng, Ke Yang, Yuling Mi, Xingsheng Hu, Xuezhi Hao, Yuchen Jiao, Xiaobing Wang, Yan Wang |
Residue substitution enhances the immunogenicity of neoepitopes from gastric cancers Huahui Yu, Jieyu Li, Yuan Yuan, Yu Chen, Jingwen Hong, Chunmei Ye, Wansong Lin, Huijing Chen, Zengqing Guo, Bo Li, Yunbin Ye |
Culturing adequate CAR-T cells from less peripheral blood to treat B-cell malignancies Lu Han, Jian Zhou, Linlin Li, Keshu Zhou, Lingdi Zhao, Xinghu Zhu, Qingsong Yin, Yufu Li, Hongqin You, Jishuai Zhang, Yongping Song, Quanli Gao |
Zhe Gong, Yue Yang, Jieyun Zhang, Weijian Guo |
Xiangdong Ye, Xueqing Wang, Wenhui Yu, Qing Yang, Yan Li, Yanxia Jin, Yanting Su, Jiaqi Song, Bo Xu, Hui Sun |
Weihong Zhang, Yuan Meng, Lin Yang, Meng Shen, Li Zhou, Runmei Li, Yang Wang, Weijiao Du, Yanjuan Xiong, Ying Han, Xinwei Zhang, Liang Liu, Xiubao Ren |
Rilan Bai, Naifei Chen, Xiao Chen, Lingyu Li, Wei Song, Wei Li, Yuguang Zhao, Yongfei Zhang, Fujun Han, Zheng Lyu, Jiuwei Cui |
Jian Wang, Fan Yang, Qian Sun, Ziqing Zeng, Min Liu, Wenwen Yu, Peng Zhang, Jinpu Yu, Lili Yang, Xinwei Zhang, Xiubao Ren, Feng Wei |